| Paul Mullarkey, MD | |
|
71 W 156th St, Suite 110, Harvey, IL 60426-4260 | |
| (773) 203-2220 | |
| Not Available |
| Full Name | Paul Mullarkey |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 20 Years |
| Location | 71 W 156th St, Harvey, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770746711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 036.129277 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John H Stroger Jr Hospital | Chicago, IL | Hospital |
| Provident Hospital Of Chicago | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cook County | 2860398088 | 619 |
News Archive
Hundreds of thousands of babies could be saved through a major global health initiative launched here today to improve newborn hospital care throughout sub-Saharan Africa.
Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
A protein molecule that 'glues' cells together and so has a key role in cancer is also responsible for many other important functions of cells, a new study has found.
A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.
› Verified 1 days ago
| Entity Name | Cook County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
Hundreds of thousands of babies could be saved through a major global health initiative launched here today to improve newborn hospital care throughout sub-Saharan Africa.
Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
A protein molecule that 'glues' cells together and so has a key role in cancer is also responsible for many other important functions of cells, a new study has found.
A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Mullarkey, MD 71 W 156th St, Suite 110, Harvey, IL 60426-4260 Ph: (773) 203-2220 | Paul Mullarkey, MD 71 W 156th St, Suite 110, Harvey, IL 60426-4260 Ph: (773) 203-2220 |
News Archive
Hundreds of thousands of babies could be saved through a major global health initiative launched here today to improve newborn hospital care throughout sub-Saharan Africa.
Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
A protein molecule that 'glues' cells together and so has a key role in cancer is also responsible for many other important functions of cells, a new study has found.
A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.
› Verified 1 days ago
Raj Chinnappan, Radiology Medicare: Accepting Medicare Assignments Practice Location: 71 W 156th St, Suite 110, Harvey, IL 60426 Phone: 713-927-0733 | |
Dr. William J. Burns, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Ingalls Dr, Harvey, IL 60426 Phone: 708-331-7800 Fax: 708-339-0695 | |
Dr. Kent C. Webb, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1 Ingalls Dr, Harvey, IL 60426 Phone: 708-331-7800 Fax: 708-339-0695 | |
Dr. Tonya Echols Cole, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Ingalls Dr, Harvey, IL 60426 Phone: 708-915-6620 | |
Dr. Sulochana D Yalavarthi, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Ingalls Dr, Cancer Care Center, Harvey, IL 60426 Phone: 708-915-6620 Fax: 708-915-3782 | |
Dr. Edward Unger, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Ingalls Dr, Harvey, IL 60426 Phone: 708-331-7800 Fax: 708-339-0695 | |
Lavanya Chekuri, MD Radiology Medicare: Medicare Enrolled Practice Location: 1 Ingalls Dr, Harvey, IL 60426 Phone: 708-331-7800 Fax: 708-339-0695 |